Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

25.45
+0.70002.83%
Pre-market: 26.941.49+5.85%04:59 EDT
Volume:296.73K
Turnover:7.49M
Market Cap:699.90M
PE:-9.47
High:25.77
Open:25.17
Low:24.78
Close:24.75
Loading ...

Design Therapeutics Q4 2024 GAAP EPS $(0.24) Beats $(0.28) Estimate

Benzinga
·
10 Mar

Trevi Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
10 Mar

Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
10 Mar

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
10 Mar

Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension

GlobeNewswire
·
10 Mar

Checkpoint Therapeutics Shares Leap Premarket on Takeover by Sun Pharma

Dow Jones
·
10 Mar

Beam Therapeutics Announces Pricing of Underwritten Offering

GlobeNewswire
·
10 Mar

Trevi Therapeutics Announces Positive Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough

PR Newswire
·
10 Mar

Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical

MT Newswires Live
·
10 Mar

Roquefort Therapeutics Announces Leadership Transition Amid Strategic Sales

TIPRANKS
·
10 Mar

Avacta Therapeutics to Present at 2025 Leerink Global Healthcare Conference

TIPRANKS
·
10 Mar

Alterity Therapeutics Reports Progress and Financial Results

TIPRANKS
·
10 Mar

India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln

Investing.com
·
10 Mar

Sun Pharma to Acquire Checkpoint Therapeutics

PR Newswire
·
10 Mar

Trevi Therapeutics to Host Conference Call and Webcast on March 10th to Share Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough

PR Newswire
·
10 Mar

Insiders At DiaMedica Therapeutics See Good Returns After Buying Stock Worth US$9.00m

Simply Wall St.
·
08 Mar